Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Cancer Res. 2019 May 21;79(14):3776–3788. doi: 10.1158/0008-5472.CAN-18-3652

Fig 5. Parameter estimation for the persister-evolution model.

Fig 5.

The panel represents results for three choices of persister growth rate λ (1/2, 1/4 and 1/8 of the untreated growth rate), and several choices of compound mutation induction probability ranging from 10−2 to 8. The colorbar represents the goodness of fit quantified by the residuals of the least-square parameter optimization in logarithmic scale.